Neurocrine Biosciences Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$959,000	$814,500	$805,500	$794,900
Gross Profit	935,800	800,700	787,900	780,900
EBITDA	189,900	193,300	235,400	299,500
EBIT	165,100	186,000	227,900	291,800
Net Income	144,400	197,900	153,700	209,500
Net Change In Cash	959,000	814,500	805,500	794,900
Free Cash Flow	128,600	136,700	390,800	214,300
Cash	332,400	266,500	713,000	340,200
Basic Shares	104,200	103,400	102,500	102,500

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$2,860,500	$2,355,300	$1,887,100	$1,488,700
Gross Profit	2,808,400	2,321,300	1,847,400	1,465,500
EBITDA	666,600	639,700	416,100	264,600
EBIT	636,500	612,600	394,800	249,000
Net Income	478,600	341,300	249,700	154,500
Net Change In Cash	2,860,500	2,355,300	1,887,100	1,488,700
Cost of Revenue				-72,000
Free Cash Flow	748,700	557,200	361,600	322,900
Cash	713,000	233,000	251,100	262,900
Basic Shares	102,500	103,700	101,000	98,900